ORIC
Oric Pharmaceuticals Inc.
Latest News for ORIC
Roth MKM analyst reiterated a Buy rating on Oric Pharmaceuticals today and set a price target of $15.00. Currently, the analyst consensus on Oric P......
In a report released today, Matthew Biegler from Oppenheimer reiterated a Buy rating on Oric Pharmaceuticals, with a price target of $15.00. Accord......
In a report released today, David Nierengarten from Wedbush maintained a Buy rating on Oric Pharmaceuticals, with a price target of $20.00. Accordi......
Oric Pharmaceuticals ( ($ORIC) ) has issued an update. On December 6, 2025, Oric Pharmaceuticals presented an update on its enozertinib (ORIC-114) ......
Oric Pharmaceuticals Inc (ORIC) has disclosed a new risk, in the Employment / Personnel category. Oric Pharmaceuticals Inc.’s strategic pipeline pr......
Wedbush analyst David Nierengarten maintained a Buy rating on Oric Pharmaceuticals today and set a price target of $20.00. Nierengarten covers the ......
The latest announcement is out from Oric Pharmaceuticals ( ($ORIC) ). Oric Pharmaceuticals announced an update on their ORIC-944 clinical trials, h......
News data is sourced from MarketXLS API and updated regularly.
Showing 7 of 7 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ORIC | $9.38 | -3.2% | 1.04M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Oric Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW